Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Simantov

Showing results (121-130 of 123) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 123 results.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 15, 2000
Differential regulation of adenosine A(1) and A(2A) receptors in serotonin transporter and monoamine oxidase A-deficient miceR Mössner, D Albert, A M Persico, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 14, 1999
Genetic background determines the extent of atherosclerosis in ApoE-deficient miceH M Dansky, S A Charlton, J L Sikes, et al.
British Journal of Cancer|August 2, 2006
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysisT Eisen, T Ahmad, K T Flaherty, et al.
Pageof 13

Showing results (121-130 of 123) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 123 results.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 15, 2000
Differential regulation of adenosine A(1) and A(2A) receptors in serotonin transporter and monoamine oxidase A-deficient miceR Mössner, D Albert, A M Persico, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 14, 1999
Genetic background determines the extent of atherosclerosis in ApoE-deficient miceH M Dansky, S A Charlton, J L Sikes, et al.
British Journal of Cancer|August 2, 2006
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysisT Eisen, T Ahmad, K T Flaherty, et al.
Pageof 13